Phenylalanine hydroxylase (PAH) drugs for Phenylketonuria

2 tracked Phenylalanine hydroxylase (PAH) drugs in the Phenylketonuria race. The class explanation lives on the Phenylalanine hydroxylase (PAH) page; the full indication pipeline across every mechanism is on the Phenylketonuria page.

2 approved / phase 4

Head-to-head evidence: Sapropterin Dihydrochloride (Kuvan) vs Sepiapterin

The roster

← all Phenylalanine hydroxylase (PAH) drugs